17 April 2018Biotechnology

Shire to sell oncology business for $2.4bn

Biotech company Shire has revealed plans to sell its oncology business for $2.4 billion to France-based Servier.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

Asia-Pacific

Takeda makes fourth offer to buy Shire

23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

Asia-Pacific

Takeda mulls Shire acquisition bid

3 April 2018 Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.

More on this story

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

Asia-Pacific

Takeda makes fourth offer to buy Shire

23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

Asia-Pacific

Takeda mulls Shire acquisition bid

3 April 2018 Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.

More on this story

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

Asia-Pacific

Takeda makes fourth offer to buy Shire

23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

Asia-Pacific

Takeda mulls Shire acquisition bid

3 April 2018 Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.